← Back to Search

Local Anesthetic

1% chloroprocaine for Decreased Discharge Time After Hemorrhoidectomy

Phase 2
Waitlist Available
Led By Iyabo Muse, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 160 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new spinal anesthetic called Chloroprocaine on patients having hemorrhoid surgery. The goal is to see if it helps them recover and leave the hospital faster compared to another anesthetic. Chloroprocaine works by numbing the lower body and blocking pain signals. Chloroprocaine is a short-acting local anesthetic that has been used for spinal anesthesia in outpatient surgery.

Eligible Conditions
  • Decreased Discharge Time After Hemorrhoidectomy
  • Motor and Sensory Blockade
  • Spinal Anesthesia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 160 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 160 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
discharge time (voiding time)
recovery time
Secondary study objectives
evidence of TNS
evidence of hypotension

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1% Chloroprocaine (PF)Experimental Treatment1 Intervention
1% Chloroprocaine is an ester-linked local anesthetic with the shortest duration of action of all local anesthetics.
Group II: 0.75% bupivacaineActive Control1 Intervention
0.75% bupivacaine is a amino-amide anesthetic local anesthetic. It is hyperbaric in nature due to addition of dextrose.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
1% chloroprocaine
2019
Completed Phase 2
~110

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
456 Previous Clinical Trials
588,360 Total Patients Enrolled
Iyabo Muse, MDPrincipal InvestigatorMontefiore Medicial Center
1 Previous Clinical Trials
65 Total Patients Enrolled
Elilary Montilla Medrano, MDPrincipal InvestigatorMontefiore Medicial Center
2 Previous Clinical Trials
99 Total Patients Enrolled
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top